{
  "paper_metadata": {
    "pmid": "39112608",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses various TTR variants associated with hereditary transthyretin amyloidosis, including demographic and clinical data of affected individuals."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.30G>A",
      "protein_notation": "p.Val10Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 16,
        "demographics": "Median age 69.5 years, 81.3% male",
        "phenotype": "ATTRv amyloidosis with confirmed polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 16,
        "affected_count": 16,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "M #5",
          "age_at_evaluation": 62,
          "age_at_onset": 23,
          "age_at_diagnosis": null,
          "sex": "M",
          "affected_status": "affected",
          "phenotype_details": "FAP stage 3, mixed phenotype",
          "evidence_sentence": "Subject #5 has a TTR variant V30M, age at onset 23."
        },
        {
          "individual_id": "M #6",
          "age_at_evaluation": 58,
          "age_at_onset": 23,
          "age_at_diagnosis": null,
          "sex": "M",
          "affected_status": "affected",
          "phenotype_details": "FAP stage 3, mixed phenotype",
          "evidence_sentence": "Subject #6 has a TTR variant V30M, age at onset 23."
        },
        {
          "individual_id": "M #7",
          "age_at_evaluation": 64,
          "age_at_onset": 69,
          "age_at_diagnosis": null,
          "sex": "M",
          "affected_status": "affected",
          "phenotype_details": "FAP stage 2, mixed phenotype",
          "evidence_sentence": "Subject #7 has a TTR variant V30M, age at onset 69."
        },
        {
          "individual_id": "M #8",
          "age_at_evaluation": 64,
          "age_at_onset": 75,
          "age_at_diagnosis": null,
          "sex": "M",
          "affected_status": "affected",
          "phenotype_details": "FAP stage 2, mixed phenotype",
          "evidence_sentence": "Subject #8 has a TTR variant V30M, age at onset 75."
        },
        {
          "individual_id": "M #16",
          "age_at_evaluation": 56,
          "age_at_onset": 70,
          "age_at_diagnosis": null,
          "sex": "M",
          "affected_status": "affected",
          "phenotype_details": "FAP stage 2, mixed phenotype",
          "evidence_sentence": "Subject #16 has a TTR variant V30M, age at onset 70."
        }
      ],
      "functional_data": {
        "summary": "The TTR V30M variant is associated with hereditary transthyretin amyloidosis, leading to amyloid fibril deposition.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Table 1, Row 5",
      "additional_notes": "The study included patients with various TTR variants, but only V30M was detailed in the individual records.",
      "key_quotes": [
        "Hereditary transthyretin (ATTRv) amyloidosis is a rare, adult-onset, progressive, multisystemic condition caused by TTR pathogenic variants.",
        "The clinical course is progressive and disabling and leads to death within 4\u201315 years from onset if left untreated."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Baseline demographic and clinical characteristics of the patients with hereditary transthyretin amyloidosis (n=16)",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding TTR variants were extracted successfully."
  }
}